Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

腎不全による糖尿病.

E A Friedman

    Lancet (London, England)
    |November 29, 1986
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    What is our duty to a "hateful" patient? Differing approaches to a disruptive dialysis patient.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·1999
    Same author

    Predicting nephrology in the 21st century.

    ASAIO journal (American Society for Artificial Internal Organs : 1992)·1999
    Same author

    Steps in integrin beta1-chain glycosylation mediated by TGFbeta1 signaling through Ras.

    Journal of cellular physiology·1999
    Same author

    Station and cervical dilation at epidural placement in predicting cesarean risk.

    Obstetrics and gynecology·1999
    Same author

    Station at onset of active phase in nulliparous patients and risk of cesarean delivery.

    Obstetrics and gynecology·1999
    Same author

    Advanced glycation end-products in diabetic nephropathy.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1999
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る